Probal Banerjee

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Immune Response

Top Venues

Cancer immunology, immunotherapy : CII

Journal of experimental & clinical cancer research : CR

International journal of molecular sciences

Gels (Basel, Switzerland)

College of Staten Island

Indian Institute of Science Faculty of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

College of Staten Island Sep 01 1994

United States

Professor :: Chemistry

Education History

Indian Institute of Science Faculty of Science Jun 01 1976 - Sep 10 1984

India

PHD :: Organic Chemistry

Publications

Jing Shen, Jiangtao Zhang, Weitai Wu, Probal Banerjee, Shuiqin Zhou
Biocompatible Anisole-Nonlinear PEG Core-Shell Nanogels for High Loading Capacity, Excellent Stability, and Controlled Release of Curcumin. Gels (Basel, Switzerland) 9 (9) (2023)
Sreyashi Samaddar, Sudarshana Purkayastha, Souleymane Diallo, Subramanyam J Tantry, Ryan Schroder, Pranavan Chanthrakumar, Michael J Flory, Probal Banerjee
The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus. International journal of molecular sciences 23 (4) (2022)
Sumit Mukherjee, Rahman Hussaini, Richard White, Doaa Atwi, Angela Fried, Samay Sampat, Longzhu Piao, Quintin Pan, Probal Banerjee
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors. Cancer immunology, immunotherapy : CII 67 (5) (2018)
Sumit Mukherjee, Angela Fried, Rahman Hussaini, Richard White, Juliet Baidoo, Sri Yalamanchi, Probal Banerjee
Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Journal of experimental & clinical cancer research : CR 37 (1) (2018)